Frontier Biotechnologies Inc. 688221.SS Stock
Frontier Biotechnologies Inc. Price Chart
Frontier Biotechnologies Inc. 688221.SS Financial and Trading Overview
| Frontier Biotechnologies Inc. stock price | 6.11 CNY |
| Previous Close | 10.85 CNY |
| Open | 10.87 CNY |
| Bid | 10.8 CNY x N/A |
| Ask | 10.81 CNY x N/A |
| Day's Range | 10.74 - 10.9 CNY |
| 52 Week Range | 10.67 - 24.38 CNY |
| Volume | 1.99M CNY |
| Avg. Volume | 4.05M CNY |
| Market Cap | 4.05B CNY |
| Beta (5Y Monthly) | 1.105691 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.88 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
688221.SS Valuation Measures
| Enterprise Value | 3.22B CNY |
| Trailing P/E | N/A |
| Forward P/E | -21.62 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 44.505806 |
| Price/Book (mrq) | 2.5369632 |
| Enterprise Value/Revenue | 35.405 |
| Enterprise Value/EBITDA | -8.259 |
Trading Information
Frontier Biotechnologies Inc. Stock Price History
| Beta (5Y Monthly) | 1.105691 |
| 52-Week Change | -30.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 24.38 CNY |
| 52 Week Low | 10.67 CNY |
| 50-Day Moving Average | 12.25 CNY |
| 200-Day Moving Average | 14.73 CNY |
688221.SS Share Statistics
| Avg. Volume (3 month) | 4.05M CNY |
| Avg. Daily Volume (10-Days) | 2.39M CNY |
| Shares Outstanding | 374.58M |
| Float | 201.47M |
| Short Ratio | N/A |
| % Held by Insiders | 49.91% |
| % Held by Institutions | 2.09% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -455.26% |
| Gross Margin | 18.50% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -10.77% |
| Return on Equity (ttm) | -22.16% |
Income Statement
| Revenue (ttm) | 90.98M CNY |
| Revenue Per Share (ttm) | 0.25 CNY |
| Quarterly Revenue Growth (yoy) | 110.09% |
| Gross Profit (ttm) | 84.74M CNY |
| EBITDA | -390017856 CNY |
| Net Income Avi to Common (ttm) | -373230784 CNY |
| Diluted EPS (ttm) | -1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.13B CNY |
| Total Cash Per Share (mrq) | 3.02 CNY |
| Total Debt (mrq) | 312.45M CNY |
| Total Debt/Equity (mrq) | 19.58 CNY |
| Current Ratio (mrq) | 4.877 |
| Book Value Per Share (mrq) | 4.261 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -323279712 CNY |
| Levered Free Cash Flow (ttm) | -399330304 CNY |
Profile of Frontier Biotechnologies Inc.
| Country | China |
| State | N/A |
| City | Nanjing |
| Address | N/A |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.frontierbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 495 |
Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health. The company's medicines address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management. Its products include Aikening, a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS; AB001, a new transdermal topical patch for the musculoskeletal joint pain treatment; and combination regimen of Albuvirtide and 3BNC117, a recombinant fully human monoclonal antibody with neutralizing effects to HIV-1 viruses. The company was founded in 2013 and is headquartered in Nanjing, China.
Q&A For Frontier Biotechnologies Inc. Stock
What is a current 688221.SS stock price?
Frontier Biotechnologies Inc. 688221.SS stock price today per share is 6.11 CNY.
How to purchase Frontier Biotechnologies Inc. stock?
You can buy 688221.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Frontier Biotechnologies Inc.?
The stock symbol or ticker of Frontier Biotechnologies Inc. is 688221.SS.
Which industry does the Frontier Biotechnologies Inc. company belong to?
The Frontier Biotechnologies Inc. industry is Biotechnology.
How many shares does Frontier Biotechnologies Inc. have in circulation?
The max supply of Frontier Biotechnologies Inc. shares is 374.58M.
What is Frontier Biotechnologies Inc. Price to Earnings Ratio (PE Ratio)?
Frontier Biotechnologies Inc. PE Ratio is now.
What was Frontier Biotechnologies Inc. earnings per share over the trailing 12 months (TTM)?
Frontier Biotechnologies Inc. EPS is -0.88 CNY over the trailing 12 months.
Which sector does the Frontier Biotechnologies Inc. company belong to?
The Frontier Biotechnologies Inc. sector is Healthcare.